What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity?

Trends in Immunology

Volumn 24, Issue 8, 2003, Pages 429-437

  Housset, Dominique ^a   Malissen, Bernard ^b  

^a CEA GRENOBLE   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; ANTIGEN BINDING; BINDING SITE; CRYSTAL STRUCTURE; HUMAN; IMMUNE RESPONSE; MOLECULAR MODEL; NONHUMAN; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; T LYMPHOCYTE ACTIVATION; THERMODYNAMICS;

EID: 0043268726     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00180-7     Document Type: Review

References (62)

1. Von Boehmer H., et al. Thymic selection revisited: how essential is it? Immunol. Rev. 191:2003;62-78.
2. Stefanova I., et al. Self-recognition promotes the foreign antigen sensitivity of naïve T lymphocytes. Nature. 420:2002;429-434.
3. Garcia K.C., et al. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science. 274:1996;209-219.
4. Garboczi D.N., et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384:1996;134-141.
5. Ding Y.H., et al. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity. 8:1998;403-411.
6. Ding Y.H., et al. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity. 11:1999;45-56.
7. Degano M., et al. A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity. 12:2000;251-261.
8. Reiser J.-B., et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat. Immunol. 1:2000;291-297.
9. Reiser J.B., et al. A T cell receptor CDR3β loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity. 16:2002;345-354.
10. Luz J.G., et al. Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(β) Interactions. J. Exp. Med. 195:2002;1175-1186.
11. Kjer-Nielsen L., et al. A structural basis for the selection of dominant αβ T cell receptors in antiviral immunity. Immunity. 18:2003;53-64.
12. Reiser J.B., et al. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 4:2003;241-247.
13. Reinherz E.L., et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science. 286:1999;1913-1921.
14. Hennecke J., et al. Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 19:2000;5611-5624.
15. Hennecke J., Wiley D.C. Structure of a complex of the human α/β T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 195:2002;571-581.
16. Rudolph M.G., Wilson I.A. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14:2002;52-65.
17. Rudolph M.G., et al. Structural and thermodynamic correlates of T cell signaling. Annu. Rev. Biophys. Biomol. Struct. 31:2002;121-149.
18. Wang J.H., Reinherz E.L. Structural basis of T cell recognition of peptides bound to MHC molecules. Mol. Immunol. 38:2002;1039-1049.
19. Bankovich A.J., Garcia K.C. Not just any T cell receptor will do. Immunity. 18:2003;7-11.
20. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today. 19:1998;395-404.
21. Garcia K.C., et al. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science. 279:1998;1166-1172.
22. Hare B.J., et al. Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor. Nat. Struct. Biol. 6:1999;574-581.
23. Willcox B.E., et al. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity. 10:1999;357-365.
24. Boniface J.J., et al. Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11446-11451.
25. Malissen B. An evolutionary and structural perspective on T cell antigen receptor function. Immunol. Rev. 191:2003;7-27.
26. James L.C., et al. Antibody multispecificity mediated by conformational diversity. Science. 299:2003;1362-1367.
27. Lang H.L., et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 3:2002;940-943.
28. Guimezanes A., et al. Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: distinct characteristics correlated with CD8 dependence. Eur. J. Immunol. 31:2001;421-432.
29. Housset D., et al. The three-dimensional structure of a T-cell antigen receptor Vα Vβ heterodimer reveals a novel arrangement of the Vβ domain. EMBO J. 16:1997;4205-4216.
30. Zerrahn J., et al. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell. 88:1997;627-636.
31. Merkenschlager M., et al. How many thymocytes audition for selection? J. Exp. Med. 186:1997;1149-1158.
32. Yokosuka T., et al. Predominant role of T cell receptor (TCR)-α chain in forming preimmune TCR repertoire revealed by clonal TCR reconstitution system. J. Exp. Med. 195:2002;991-1001.
33. Fremont D.H., et al. Structural basis of cytochrome c presentation by IE(k). J. Exp. Med. 195:2002;1043-1052.
34. Schumacher T.N., Ploegh H.L. Are MHC-bound peptides a nuisance for positive selection? Immunity. 1:1994;721-723.
35. Speir J.A., et al. Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. Immunity. 8:1998;553-562.
36. Correia-Neves M., et al. The shaping of the T cell repertoire. Immunity. 14:2001;21-32.
37. Treiner E., et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 422:2003;164-169.
38. Zeng Z., et al. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science. 277:1997;339-345.
39. Parham P., Ohta T. Population biology of antigen presentation by MHC class I molecules. Science. 272:1996;67-74.
40. Bevan M.J. High determinants density may explain the phenomenon of alloreactivity. Immunol. Today. 5:1984;128-130.
41. Matzinger P., Bevan M.J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell. Immunol. 29:1977;1-5.
42. Marrack P., et al. Major histocompatibility complex proteins and TCRs: do they really go together like a horse and carriage? J. Immunol. 167:2001;617-621.
43. Firat H., et al. Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int. Immunol. 14:2002;925-934.
44. Obst R., et al. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules. J. Exp. Med. 191:2000;805-812.
45. Cohn M. Tritope model of restrictive recognition by the TCR. Trends Immunol. 24:2003;127-131.
46. Baker B.M., et al. Identification of a crucial energetic footprint on the α1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors. J. Exp. Med. 193:2001;551-562.
47. Wu L.C., et al. Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature. 418:2002;552-556.
48. Lee P.U., et al. Role of 2CT cell receptor residues in the binding of self- and allo-major histocompatibility complexes. J. Exp. Med. 191:2000;1355-1364.
49. DeLano W.L. Unraveling hot spots in binding interfaces: progress and challenges. Curr. Opin. Struct. Biol. 12:2002;14-20.
50. Fersht A.R. Characterizing transition states in protein folding: an essential step in the puzzle. Curr. Opin. Struct. Biol. 5:1995;79-84.
51. Daggett V., et al. Structure of the transition state for folding of a protein derived from experiment and simulation. J. Mol. Biol. 257:1996;430-440.
52. Dall-Acqua W., et al. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Biochemistry. 37:1998;7981-7991.
53. Arkin M.R., et al. Binding of small molecules to an adaptive protein-protein interface. Proc. Natl. Acad. Sci. U. S. A. 100:2003;1603-1608.
54. Kraulis P.J. Molscript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.
55. Merrit E.A., Bacon D.J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277:1997;505-524.
56. Bentley G.A., et al. Crystal structure of the β chain of a T cell antigen receptor. Science. 267:1995;1984-1987.
57. Wang J., et al. Atomic structure of an αβ T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody. EMBO J. 17:1998;10-26.
58. Fields B.A., et al. Crystal structure of the Vα domain of a T cell antigen receptor. Science. 270:1995;1821-1824.
59. Pimsler M., Forman J. Use of H-2 mutations to quantitate alloreactivity: alloreactivity is strongest against H-2 antigens which are closet to self. Immunogenetics. 11:1980;111-121.
60. Widmer M.B., MacDonald H.R. Cytolytic T lymphocyte precursors reactive against mutant Kb alloantigens are as frequent as those reactive against a whole foreign haplotype. J. Immunol. 124:1980;48-51.
61. Doherty P.C., et al. Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity. Transplant Rev. 29:1976;89-124.
62. Al-Lazikani B., et al. Canonical structures for the hypervariable regions of T cell αβ receptors. J. Mol. Biol. 295:2000;979-995.